Schandrin, Aurélie
Jourdan, Julie
Chkair, Sihame
Bouvet, Sophie
Fabbro-Peray, Pascale
Abbar, Mocrane
,
Diaz, Emmanuel
Audemard, Géraldine
Delphine, Capdevielle
Macgregor, Alexandra
Rainteau, Nicolas
Brino, Coline
Larue, Aurore
Raynaud, Philippe
Duron, Thomas
Delaigue, Maeva
Véry, Etienne
Cambon, Amandine
Aoun, Ibtissam
Bastiat, Marielle
Article History
Received: 9 June 2024
Accepted: 6 May 2025
First Online: 15 May 2025
Declarations
:
: The project has been approved by a Research Ethics Committee, committee for the protection of persons (CPP) Ile de France I. It was designed in line with the Declaration of Helsinki and registered at , NCT05116514. All changes to the protocol will be submitted for ethical approval and then forwarded to investigators and participants. Additionally, during the funding process, the protocol has undergone independent peer review.Participants are informed by investigators about the trial and about the voluntary nature of their participation with both written and verbal communications. Participants are only randomized following the provision of informed consent. Persons in mandatory care, often in inpatient unit, can consent to the study if their clinical condition allows it according to medical and participant evaluation. For minors, their consent and the consent of the two legal guardians are necessary. The choice of the treatment according to the randomization is explained to the participants as well as their families.If an ancillary or post-trial study is developed, it will be submitted for ethical approval.
: Participants who give their informed consent for this study are informed of the use of their data for publication purposes. Any written or oral communication of the results of the research must receive the prior agreement of the coordinating investigator and the sponsor.
: The authors declare no competing interests.